24/7 Market News – (NASDAQ: HILS) Hillstream Biopharma Inc. shares just popped on collaboration announcement.

June 27, 2022

BRIDGEWATER, N.J., June 27, 2022 (GLOBE NEWSWIRE) — Hillstream BioPharma, Inc. (Nasdaq:HILS) (Hillstream or the Company), a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death for drug resistant and devastating cancers, today announced a collaboration with Sapien Biosciences to evaluate the synergy of HSB-1216 with immune checkpoint inhibitors.
Immune Checkpoint Inhibitors and Ferroptosis

Pages: 1 2

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.